Page last updated: 2024-11-13

d-6-methyl-8-ergolin-1-ylacetic acid amide tartrate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

D-6-methyl-8-ergolin-1-ylacetic acid amide tartrate: inhibitor of lactation; RN given refers to (8beta)-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID21124022
SCHEMBL ID11421566
MeSH IDM0045279

Synonyms (24)

Synonym
ergoline-8beta-acetamide, 6-methyl-
ergoline-8-acetamide, 6-methyl-, (8beta)-
d-6-methyl-8-ergolin-1-ylacetic acid amide tartrate
33529-63-4
alpha-d-6-methylergolinyl-8-acetamide
unii-d7hh5ogw9w
d7hh5ogw9w ,
d-8beta-(carbamoylmethyl)-6-methylergoline
SCHEMBL11421566
6-methylergoline-8.beta.-acetamide
2-((8.beta.,10.xi.)-6-methylergolin-8-yl)acetamide
ergoline-8.beta.-acetamide, 6-methyl-
.alpha.-d-6-methylergolinyl-8-acetamide
6-methylergoline-8-acetamide, (8-.beta.)-
d-8.beta.-(carbamoylmethyl)-6-methylergoline
j389.146a ,
2-((6ar,9s)-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo(4,3-fg)quinoline-9-yl)acetamide
acetamide, 2-((8.beta.,10.xi.)-6-methylergolin-8-yl)-
ergoline-8-acetamide, 6-methyl-, (8.beta.)-
d-6-methylergolin-8-ylacetamide
(8-.beta.)-6-methylergoline-8-acetamide
Q27276212
(8-beta)-6-methylergoline-8-acetamide
2-[(6ar,9s,10ar)-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinolin-9-yl]acetamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.05 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]